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Abstract
Background: Headache such as migraine is associated with stroke. Studies focused on primary headache disorders
(PHDs) as a risk factor for stroke are limited. The purpose of this population-based cohort study was to explore
whether patients with PHDs were at a high risk for developing stroke.
Methods: A total of 1346 patients with PHDs were enrolled and compared with 5384 age-, gender- and co-morbidity-
matched control cohorts. International Classification of Diseases, Clinical Modification codes were administered for the
definition of PHDs, stroke, and stroke risk factors. Cox proportional-hazards regressions were performed for investigating
hazard ratios (HR).
Results: PHDs patients exhibited a 1.49 times (95% CI :1.15–1.98, p < 0.01) higher risk for developing ischaemic stroke
compared with that of control cohorts. Both migraine (HR = 1.22, 95% CI :1.13–1.97, p < 0.05) and tension-type headache
(HR = 2.29, 95% CI :1.22–2.80, p < 0.01) were associated with an increased risk of ischemic stroke. Females with PHDs were
at greater risk of developing ischaemic stroke (HR = 1.49, 95% CI :1.13–1.90, p < 0.01) than those without PHDs. PHDs
patient aged 45 to 64 years displayed significantly higher risk to develop ischaemic stroke (HR=1.50, 95% CI: 1.11–2.10, p
< 0.05) than the matched controls. The impact of PHDs on ischaemic stroke risk became gradually apparent by different
following time intervals beyond 2 years after first diagnosis.
Conclusion: PHDs is suggestive of an incremental risk for ischaemic stroke with gender-dependent, age-specific and
time-dependent characteristics.
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Background
Stroke is one of leading causative factors of permanent
disability and mortality worldwide. It is considered as a
preventive disorder and preventive interventions are of
more considerable value compared with therapeutic
approaches [1]. The crucial risk factors for stroke had
been established, including non-modifiable (age, gender)
and modifiable (hypertension, diabetes, dyslipidemia,
smoking, and atrial fibrillation) [2]. Up to 40% patients
with stroke have been reported to have medical conditions
in addition to the traditional risk factors, which contribute
to pathogenesis of stroke in certain populations [3, 4]. It is
suggested that investigation of certain medical diseases or
conditions to establish a full-scale account of risk factors
for stroke achieve an appropriate prevention with
great value.
Primary headache disorders (PHDs) include migraine,
tension-type headache, cluster headache, and other
primary headaches [5]. PHDs is known as recurrent or
persistent pain of head without any clear underlying
mechanism, which significantly impair patients’ life
quality [6, 7]. Migraine is reported as a risk factor of stroke
[8], whereas non- migraine headaches have received less
notice regardless of high prevalence [9, 10]. Given the
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advantages of the Taiwan National Health Insurance pro-
gram, the present study was intended to explore increased
risks of stroke in patients with PHDs.
Methods
Data sources
The National Health Insurance (NHI) system, insti-
tuted in 1995, is a mandatory social insurance pro-
gram that offers comprehensive health care coverage
to all residents of Taiwan. This retrospective study
was conducted using the data retrieved from Longi-
tudinal Health Insurance Database (LHID 2005) re-
leased by Taiwan National Health Research Institute
(NHRI) covering clinical data between 1997 and
2010. The LHID 2005 consisted of declared informa-
tion, including records of inpatient, outpatient, and
ambulatory care services of one million individuals
insured, who randomly extracted from a database of
more than 25 million cases. The International Classi-
fication of Diseases, Ninth Revision, Clinical Modifi-
cation (ICD-9-CM) was employed for classification
of diseases. According to Taiwan NHRI, there was
no significant difference in the distribution of age
and gender between the patients in the LHID 2005
and the original database [11]. The patient identity
was blinded as a scrambled and anonymous number
to protect the privacy of the insured people. Previ-
ous reports have shown the reliability of the diagno-
sis coding in the LHID [12, 13]. The study protocol
was reviewed and approved by Institutional Review
Board of Tri-Service General Hospital (TSGHIRB
No.: 1-104-05-112).
Study population
From 967,854 individual outpatient care data in the
LHID from 2000 to 2005, patients with new diagnosis
of PHD were identified and included. The subjects
with a previous diagnosis of PHDs and stroke or with
lacking identification of sex or individuals under 18
years of age were excluded. Patients were diagnosed
with migraine (ICD-9-CM 346), tension-type headache
(ICD-9-CM 307.81), and other headache syndromes
(ICD-9-CM 339) for the first time from 2000 to 2005
(N = 1,346), as the study cohort. We randomly se-
lected 5,384 individuals with a ratio of 4:1, to match
the PHDs group according to age, gender and comor-
bidities include hypertension, diabetes mellitus, is-
chaemic heart diseases, hyperlipidaemia and atrial
fibrillation. The diagnosis date of PHDs was consid-
ered as the index date. Each case was then followed
up from the index date up to the date of stroke
developed. For cases who did not suffer a stroke, the
endpoint of tracking was defined as the last day of
the study period (December 31, 2010) or the termin-
ation date of insurance.
Definition of stroke subtypes and comorbidities
Subtypes of stroke were divided into ischaemic stroke
(ICD-9-CM 433–437) and haemorrhagic (ICD-9-CM
430–432), respectively. Brain image such as computed
tomography (CT) or magnetic resonance imaging
(MRI) was used to verify the stroke diagnosis, which
was not established if the patient was merely given
stroke ICD codes without the procedure code of CT
or MRI. Comorbidities known as major vascular risk
factors including hypertension (ICD-9-CM 401–405),
diabetes mellitus (ICD-9-CM 250), ischaemic heart
diseases (ICD-9-CM 410–414), hyperlipidaemia (ICD-
9-CM 272) and atrial fibrillation (ICD-9-CM 427.3)
were identified prior to the index date based on the
above ICD classification.
Statistical analyses
Pearson chi-square test was administered to check the dif-
ferences of categorical variables such as age groups, gen-
der, hypertension, diabetes, ischaemic heart diseases,
hyperlipidaemia and atrial fibrillation between the study
and control cohort. After adjustment for the mentioned
variables, Cox proportional hazard regressions were
employed to evaluate the adjusted hazard ratio (HR) for
the influence of PHDs on developing stroke. Kaplan-
Meier analysis was performed to estimate the cumulative
incidence of stroke for these two groups. Statistical Pack-
age for the Social Science version 22.0 (SPSS Inc., Chi-
cago, IL, USA) was administered for all statistical analyses.
Results
In this study, we identified and included 1,346 patients
diagnosed with PHDs and 5,384 age- and gender-
matched controls for comparison. The demographic fea-
tures were presented in Table 1, showing that the distri-
bution of age, sex, and comorbidities of the study group
were similar to the control group. The results revealed
that 100 (incidence: 162.62/10,000 person-years) all
stroke events developed in the study cohort and 287 (in-
cidence: 116/10,000 person-years) in the control group
over a five-year observation period (Table 2). In the sub-
group analysis, individuals with PHDs had a 1.49 times
(95% CI: 1.15–1.98, p < 0.01) higher risk to develop is-
chaemic stroke, instead of haemorrhagic stroke, com-
pared with the control group (Table 2).
To investigate whether PHDs is an age-dependent risk
factor for ischaemic stroke, we stratified patients into 3
groups by age (<45, 45 to 64, and ≥65 years). The PHDs
group had significantly greater risk for development of
ischaemic stroke than the control cohort in the
subgroup aged 45 to 64 (HR=1.50, 95% CI: 1.11–2.10,
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p < 0.05). However, no significant difference was found
between the PHDs group and matched controls with age
<45 and ≥65 years. We also examined if PHDs is a
gender-dependent risk factor for developing ischaemic
stroke using the Cox regression analysis. The result of
gender-specific analysis revealed that women with PHDs
had higher risk to develop ischaemic stroke (HR = 1.49,
95% CI: 1.13–1.90, p < 0.01) than those without PHDs.
Furthermore, we analyzed the incidence of stroke and
stroke subtypes using multivariate Cox proportional haz-
ards regression analysis according to time intervals. Our
data revealed that patients with PHDs were likely to
develop ischaemic stroke beyond 2 years after diagnosis
(HR = 1.40, 95% CI: 1.00–1.90, p < 0.05) (Table 3).
Significantly higher cumulative incidence of ischaemic
stroke in the PHDs group than in the matched controls
was observed by Kaplan-Meier analysis (Fig. 1).
We next investigated the impact of the PHDs
subsets on stroke. Distribution of PHDs was pre-
sented in Additional file 1: Table S1. The subgroup
analysis showed that patients with either migraine or
tension-type headache had a higher risk to develop
ischaemic stroke (Table 4). Compared to the non-
PHDs group, the risks of ischaemic stroke were 1.22
(95% CI: 1.13–1.97) and 2.29 (95% CI: 1.22–2.80)
times higher in migraine and tension-type headache
group, respectively.
Discussion
In this nationwide, population-based cohort study, we
found an incremental risk of ischaemic stroke in patients
with PHDs. After adjusting for age, gender, and medical
comorbidities, PHDs patients were more likely to de-
velop ischemic stroke than matched controls. A sub-
group analysis revealed that both migraine and tension-
type headache were associated with an increased risk of
ischemic stroke. Moreover, we showed that female PHDs
patients had higher likelihood to develop ischaemic
stroke. In addition, we found that the middle age group
(aged 45 to 64 years) with PHDs was more susceptible
to development of ischaemic stroke. It is worth noting
that the impact of PHDs on developing ischaemic stroke
was significant with an interval of at least 2 years follow-
up and increased over time.
Accumulating evidence has highlighted the association
of ischaemic stroke with previous migraine [8, 14–16]. A
meta-analysis reviewing 13 case–control, 10 cohort, and
two cross sectional studies has suggested that migraine
is one of independent risk factors for ischaemic stroke
[14]. However, the power of this meta-analysis is re-
stricted chiefly by the case–control nature of many of
the researches, with their innate susceptibility to recall
bias. Non-migraine or chronic headache has been linked
to an incremental risk of all strokes [17, 18], but the evi-
dence is conflicting. Neither of these studies compared
the association of chronic headache with stroke sub-
types. In this longitudinal study using nation-based data-
base, we observed that patients with either migraine or
tension-type headache had an increased risk for develop-
ment of ischaemic stroke.
Recently, the mechanisms underlying migraine as a pos-
sible risk factor of ischaemic stroke have been postulated.
Speculated mechanisms consist mainly of vasospasm [19,
20], prolonged of cortical spreading depression [21], plate-
let hyperaggregability [22, 23], increased prothrombotic
factors [24, 25], endothelial abnormalities [26, 27] and al-
teration of arterial function [28]. In addition, a recent
systemic review and meta-analysis study [29] has reported
an association between migraine with myocardial infarc-
tion, The study suggests that the association is more
obvious and evident in women, which was in line with
results of the present study.
Recently, studies have shown a subcortical white mat-
ter (WM) hyperintensity in migraine patients [30, 31].
An incremental risk of WM hyperintensity has been
observed in patients with tension-type headache, [32]
indicating that the link spreads to non-migrainous
headaches. WM hyperintensity has been suggested as an
incomplete process of ischemia with a result of arteriolo-
sclerosis of small vessels in the cerebrum [33]. It is also
considered as small vessel alterations leading dysfunc-
tion of blood–brain barrier, and subsequent chronic
Table 1 Baseline demographic status and co-morbidities com-







N = 5,384 (%)
p-value
Age, years (SD)a 47.38 (14.56) 46.74 (15.77) 0.183
<45 820 (60.92) 3,280 (60.92)
45–64 404 (30.01) 1,616 (30.01)
≥65 122 (9.07) 488 (9.07)
Sex 0.999
Female 959 (71.25) 3,836 (71.25)
Male 387 (28.75) 1,548 (28.75)
Co-morbidities
Hypertension 72 (5.35) 305 (5.66) 0.342
DM 25 (1.86) 101 (1.88) 0.732
IHD 14 (1.04) 53 (0.98) 0.476
Hyperlipidaemia 22 (1.63) 99 (1.84) 0.142
AF 1 (0.07) 7 (0.13) 0.503
Event (strokes) in the
endpoint
100 (7.43) 287 (5.33) 0.002
Years of follow-up (SD)a 4.57 (1.22) 4.60 (1.20) 0.465
Abbreviation: SD standard deviation, PHDs primary headache disorders, DM
diabetes mellitus, IHD ischaemic heart disease, AF atrial fibrillation
aStudent’s t-test
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diffusion of macromolecules and fluids in the white
matter; oxidative stress, dysfunction of endothelium
and mechanisms involved in vascular regulation [34].
WM hyperintensity is related to an incremental risk
for ischaemic stroke [35, 36]. As a result, subtle brain
WM changes may lead to the higher risk for ischeamic
stroke in PHDs patients. Further researches are necessary
to verify these suppositions.
Compared to individuals without PHDs, patients
with migraine had a null risk of haemorrhagic stroke
in this study, which is consistent with the poor
correlation between migraine and risk of haemor-
rhagic stroke in a previous study [37]. However, these
findings differ from prior studies [15, 38] that indi-
cated migraine was associated with an increased risk
of haemorrhagic stroke. Moreover, migraine with aura
rather than migraine without aura played a more
important role in the overall increase of haemorrhagic
stroke risk. Differences in methodological aspects and
clinical settings might contribute to the discrepancies
[39].
The prevalence of PHDs was higher for women than
for men in our study as has been formerly reported [40].
This has been considered as a contribution of the effect
of female hormones especially estrogen. Researches have
shown that the risk for ischaemic stroke was increased
in women who had migraine with aura and appeared to
be exacerbated by smoking, oral contraceptive use and
age <45 years [14]. Even though there are considerable
methodological limitations in these studies [41]. Recent
prospective cohort study [42] provided evidence that
women with migraine were associated with an increased
risk for major cardiovascular disease including myocar-
dial infarction, stroke, and angina/coronary revasculari-
zation procedures, despite the mechanisms remain
unclear. Similarly, the risk of ischaemic stroke was
higher in the women with PHDs than in the control
group in the present study.
Table 2 Incidence of stroke and stroke subtype and multivariate Cox proportional hazards regression analysis measured hazard ratio
for study cohort
Variable PHDs cohort Comparison cohort Adjusted HR
(95% CI)Event PYs Rate Event PYs Rate
All strokes 100 6,149 162.62 287 24,742 116.00 1.40 (1.13–1.68)**
Haemorrhagic 4 6,149 6.50 30 24,742 12.12 0.55 (0.25–1.58)
Ischaemic 96 6,149 156.11 257 24,742 103.87 1.49 (1.15–1.98)**
<45 years
All strokes 13 2,951 44.05 33 12,539 26.32 1.66 (0.79–2.97)
Haemorrhagic 1 2,951 3.39 7 12,539 5.58 0.63 (0.10–4.00)
Ischaemic 12 2,951 40.66 26 12,539 20.73 1.95 (0.97–3.74)
45–64 years
All strokes 50 2,568 194.73 124 9,222 134.46 1.43 (1.03–2.00)*
Haemorrhagic 3 2,568 11.68 13 9,222 14.10 0.81 (0.15–2.77)
Ischaemic 47 2,568 183.04 111 9,222 120.36 1.50 (1.11–2.10)*
≧65 years
All strokes 37 631 586.68 130 2,981 436.14 1.33 (0.91–1.91)
Haemorrhagic 0 631 0 10 2,981 33.55 0
Ischaemic 37 631 586.68 120 2,981 402.59 1.42 (0.99–2.08)
Male
All strokes 35 1,730 202.36 101 6,918 146.00 1.37 (0.91–2.02)
Haemorrhagic 3 1,730 17.35 15 6,918 21.68 0.80 (0.25–2.70)
Ischaemic 32 1,730 185.02 86 6,918 124.32 1.46 (0.91–2.10)
Female
All strokes 65 4,420 147.06 186 17,825 104.35 1.40 (1.04–1.80)*
Haemorrhagic 1 4,420 2.26 15 17,825 8.42 0.26 (0.02–2.00)
Ischaemic 64 4,420 144.80 171 17,825 95.93 1.49 (1.13–1.90)**
Model adjusted for age, sex, hypertension, DM, IHD, hyperlipidaemia, AF
Abbreviation: PYs person-years, Rate incidence rate, per 10,000 person-years, PHDs primary headache disorders, DM diabetes mellitus, IHD ischaemic heart disease,
AF atrial fibrillation; HR: hazard ratio
*p < 0.05; **p < 0.01
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Stroke is often considered an aging-related disorder,
and the incidence of stroke grows with age among
the general population. Researches show the risk of
stroke approximately doubles each decade after age
55 [2]. However, strokes can develop at any age in
reality. In this study, we found that the risk for
development of ischaemic stroke was significantly
greater in the PHDs group aged 45 to 64, instead of
the elderly PHDs group (aged ≥65 years), suggesting
that increasing age was not an absolute risk factor
for developing ischaemic stroke in individuals with
PHDs. Our results that there was no significant
higher risk of ischaemic stroke in the PHDs group
aged <45 years are in a disagreement with a previous
study in which [14] migraine with aura was associ-
ated with an increased risk of ischemic stroke and
the increase appeared to be exacerbated by smoking,
oral contraceptive use and age <45 years. The differ-
ences might be explained by study designs and envir-
onmental factors involved. Furthermore, the impact
of PHDs on ischaemic stroke risk was significant
after 2 years of follow-up and increased over time,
supporting the hypothesis of the chronic effect of
PHDs on ischaemic stroke risk.
Study limitations
There are certain limitations in this study. Firstly,
medication likes hormonal contraceptives or life
habits, such as smoking, drinking, customs of exercise
and food that may affect the stroke risk did not in-
clude in the study. Secondly, our data from the huge
database may comprise unrecognized recurrent indi-
viduals that may have suffered PHDs and stroke prior
to1996 when NIH began to administer. Moreover,
coding error might happen in the dataset. Thirdly,
potential diagnosis biases and misclassification might
exist due to the diagnoses of PHDs were ascertained
retrospectively without further confirmations by
headache experts. At last, our results only revealed an
association instead of demonstrating straightforward
relationship. Further researches are necessary to
elaborate the mechanism underlying the association
showed in this study.
Table 3 Incidence of stroke and stroke subtype and multivariate Cox proportional hazards regression analysis measured hazard ratio
for study cohort by various time intervals
Variable PHDs cohort Comparison cohort Adjusted HR
(95% CI)Event PYs Rate Event PYs Rate
Follow <1 year
All strokes 42 22 19,337.02 96 57 16,949.15 1.24 (0.85–1.87)
Haemorrhagic 2 22 920.81 12 57 2,118.64 0.49 (0.14–2.10)
Ischaemic 40 22 18,416.21 84 57 14,830.51 1.31 (0.91–1.88)
Follow ≧1, <2 years
All strokes 13 43 3,046.64 55 176 3,122.52 1.00 (0.55–1.80)
Haemorrhagic 0 43 0 5 176 283.87 0
Ischaemic 13 43 3,046.64 50 176 2,838.65 1.04 (0.43–1.86)
Follow ≧2 years
All strokes 45 6,085 73.95 136 24,510 55.49 1.33 (1.05–1.88)*
Haemorrhagic 2 6,085 3.29 13 24,510 5.30 0.63 (0.11–2.54)
Ischaemic 43 6,085 70.66 123 24,510 50.18 1.40 (1.00–1.90)*
Model adjusted for age, sex, hypertension, DM, IHD, hyperlipidaemia, AF
Abbreviation: PYs person-years, Rate incidence rate, per 10,000 person-years, PHDs primary headache disorders, DM diabetes mellitus, IHD ischaemic heart disease,
AF atrial fibrillation
*p < 0.05
Fig. 1 The cumulative incidence of ischemic stroke for the individual
with and without primary headache disorders
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Conclusion
In this study, we provide subjective evidence supporting
the hypothesis that PHDs patients are at relatively high
risk for developing ischaemic stroke. The increase in the
risk of ischaemic stroke associated with PHDs was
mainly associated with migraine and tension-type
headache rather than other primary headaches. PHDs
are considered to be an age-specific, gender dependent
and time-dependent risk factor of ischaemic stroke.
These findings suggest that preventive strategies of
ischaemic stroke might be ameliorated by being more
careful with subgroups of patients, especially middle-
aged (45- to 64-year) and female individuals with
PHDs.
Additional file
Additional file 1: Table S1. Distribution of PHDs. (DOC 55 kb)
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Table 4 Incidence of stroke and stroke subtype and multivariate Cox proportional hazards regression analysis measured hazard ratio
for study cohort by PHDs subtype
Variable PHDs cohort Comparison cohort Adjusted HR
(95% CI)Event PYs Rate Event PYs Rate
Total
All strokes 100 6,149 162.62 287 24,742 116.00 1.40 (1.13–1.68)**
Haemorrhagic 4 6,149 6.50 30 24,742 12.12 0.55 (0.25–1.58)
Ischaemic 96 6,149 156.11 257 24,742 103.87 1.49 (1.15–1.98)**
Migraine
All strokes 65 5,235 124.16 287 24,742 116.00 1.15 (1.04–1.69)*
Haemorrhagic 3 5,235 5.73 30 24,742 12.12 0.44 (0.21–1.57)
Ischaemic 62 5,235 118.43 257 24,742 103.87 1.22 (1.13–1.97)*
Tension-type headache
All strokes 35 996 351.41 287 24,742 116.00 2.16 (1.25–2.77)**
Haemorrhagic 1 996 10.04 30 24,742 12.12 0.86 (0.23–1.64)
Ischaemic 34 996 341.37 257 24,742 103.87 2.29 (1.22–2.80)**
Model adjusted for age, sex, hypertension, DM, IHD, hyperlipidaemia, AF
Abbreviation: PYs person-years, Rate incidence rate, per 10,000 person-years, PHDs primary headache disorders, DM diabetes mellitus, IHD ischaemic heart disease,
AF atrial fibrillation
*p < 0.05; **p < 0.01
Tsai et al. The Journal of Headache and Pain  (2016) 17:108 Page 6 of 7
References
1. Murray CJ, Lopez AD (1997) Mortality by cause for eight regions of the
world: Global Burden of Disease Study. Lancet 349:1269–1276
2. Fonarow GC, Reeves MJ, Zhao X et al (2010) Age-related differences in
characteristics, performance measures, treatment trends, and outcomes in
patients with ischaemic stroke. Circulation 121:879–891
3. Whisnant JP (1997) Modeling of risk factors for ischaemic stroke. The Willis
Lecture. Stroke 28:1840–1844
4. Donnan GA, Fisher M, Macleod M, Davis SM (2008) Stroke. Lancet 371:1612–1623
5. Headache Classification Committee of the International Headache Society
(IHS) (2013) The International Classification of Headache Disorders, 3rd
edition (beta version). Cephalalgia 33:629–808
6. Lantéri-Minet M, Duru G, Mudge M, Cottrell S (2011) Quality of life
impairment, disability and economic burden associated with chronic daily
headache, focusing on chronic migraine with or without medication
overuse: a systematic review. Cephalalgia 14:837–850
7. Abu Bakar N, Tanprawate S, Lambru G, Torkamani M, Jahanshahi M, Matharu M
(2016) Quality of life in primary headache disorders: A review. Cephalalgia
36:67–91
8. Spector JT, Kahn SR, Jones MR, Jayakumar M, Dalal D, Nazarian S (2010)
Migraine headache and ischaemic stroke risk: an updated meta-analysis.
Am J Med 123:612–624
9. World Health Organization: Headache disorders. Fact sheet. Available from
URL: http://www.who.int/mediacentre/factsheets/fs277/en/. Accessed on 22
Apr 2016
10. Steiner TJ (2005) Lifting the burden: the global campaign to reduce the
burden of headache worldwide. J Headache Pain 6:373–377
11. National Health Insurance Research Database, Taiwan. Available from URL:
http://nhird.nhri.org.tw/en/index.html. Accessed 31 Oct 2016
12. Kang JH, Chen YH, Lin HC (2010) Comorbidity profiles among patients with
ankylosing spondylitis: a nationwide population-based study. Ann Rheum Dis
69:1165–1168
13. Shen CC, Tsai SJ, Perng CL, Kuo BI, Yang AC (2013) Risk of Parkinson disease after
depression: a nationwide population-based study. Neurology 81:1538–1544
14. Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T (2009) Migraine
and cardiovascular disease: systematic review and meta-analysis. BMJ 339:
b3914
15. Kurth T, Kase CS, Schürks M, Tzourio C, Buring JE (2010) Migraine and risk of
haemorrhagic stroke in women: prospective cohort study. BMJ 341:c3659
16. Monteith TS, Gardener H, Rundek T, Elkind MSV, Sacco RL (2015) Migraine
and risk of stroke in older adults: Northern Manhattan Study. Neurology 85:
715–721
17. Jousilahti P, Tuomilehto J, Rastenyte D, Vartiainen E (2003) Headache and
the risk of stroke: a prospective observational cohort study among 35,056
Finnish men and women. Arch Intern Med 163:1058–1062
18. Merikangas KR, Fenton BT, Cheng SH, Stolar MJ, Risch N (1997) Association
between migraine and stroke in a large-scale epidemiological study of the
United States. Arch Neurol 54:362–368
19. Woods RP, Iacoboni M, Mazziotta JC (1994) Brief report: bilateral spreading
cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med
331:1689–1692
20. Olesen J, Friberg L, Olsen TS et al (1993) Ischaemia-induced (symptomatic)
migraine attacks may be more frequent than migraine-induced ischaemic
insults. Brain 116(Pt 1):187–202
21. Kurth T, Chabriat H, Bousser MG (2012) Migraine and stroke: a complex
association with clinical implications. Lancet Neurol 11:92–100
22. D’Andrea G, Hasselmark L, Alecci M et al (1994) Platelet secretion from dense
and alpha-granules in vitro in migraine with or without aura. J Neurol
Neurosurg Psychiatry 57:557–561
23. Zeller JA, Frahm K, Baron R et al (2004) Platelet-leukocyte interaction and
platelet activation in migraine: a link to ischaemic stroke? J Neurol
Neurosurg Psychiatry 75:984–987
24. Hering-Hanit R, Friedman Z, Schlesinger I, Ellis M (2001) Evidence for
activation of the coagulation system in migraine with aura. Cephalalgia
21:137–139
25. Waeber C, Moskowitz MA (2005) Migraine as an inflammatory disorder.
Neurology 64:S9–S15
26. Mawet J, Kurth T, Ayata C (2015) Migraine and stroke: in search of shared
mechanisms. Cephalalgia 35:165–181
27. Tietjen GE (2009) Migraine as a systemic vasculopathy. Cephalalgia 29:987–996
28. Sacco S, Ripa P, Grassi D et al (2013) Peripheral vascular dysfunction in
migraine: a review. J Headache Pain 14:80
29. Sacco S, Ornello R, Ripa P et al (2015) Migraine and risk of ischaemic heart
disease: a systematic review and meta-analysis of observational studies.
Eur J Neurol 22:1001–1011
30. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM
(2003) Silent brain infarcts and the risk of dementia and cognitive decline.
N Engl J Med 348:1215–1222
31. Kruit MC, van Buchem MA, Launer LJ, Terwindt GM, Ferrari MD (2010)
Migraine is associated with an increased risk of deep white matter lesions,
subclinical posterior circulation infarcts and brain iron accumulation: the
population-based MRI CAMERA study. Cephalalgia 30:129–136
32. Bell BD, Primeau M, Sweet JJ, Lofland KR (1999) Neuropsychological
functioning in migraine headache, nonheadache chronic pain, and mild
traumatic brain injury patients. Arch Clin Neuropsychol 14:389–399
33. Tana C, Tafuri E, Tana M et al (2013) New insights into the cardiovascular
risk of migraine and the role of white matter hyperintensities: is gold all
that glitters? J Headache Pain 14:9
34. Xiong YY, Mok V (2011) Age-related white matter changes. J Aging Res
2011:617927
35. Kuller LH, Longstreth WT Jr, Arnold AM et al (2004) White matter
hyperintensity on cranial magnetic resonance imaging: a predictor of stroke.
Stroke 35:1821–1825
36. Debette S, Markus HS (2010) The clinical importance of white matter
hyperintensities on brain magnetic resonance imaging: systematic review
and meta-analysis. BMJ 341:c3666
37. Gaist D, González-Pérez A, Ashina M, Rodríguez LA (2014) Migraine and
risk of hemorrhagic stroke: a study based on data from general practice.
J Headache Pain 15:74
38. Sacco S, Ornello R, Ripa P, Pistoia F, Carolei A (2013) Migraine and
hemorrhagic stroke: a meta-analysis. Stroke 44:3032–3038
39. Ornello R, Pistoia F, Degan D, Carolei A, Sacco S (2015) Migraine and
hemorrhagic stroke: data from general practice. J Headache Pain 16:8
40. Macgregor EA, Rosenberg JD, Kurth T (2011) Sex-related differences in
epidemiological and clinic-based headache studies. Headache 51:843–859
41. Petitti DB (2003) Clinical practice. Combination estrogen-progestin oral
contraceptives. N Engl J Med 349:1443
42. Kurth T, Winter AC, Eliassen AH et al (2016) Migraine and risk of
cardiovascular disease in women: prospective cohort study. BMJ 353:i2610
Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
Tsai et al. The Journal of Headache and Pain  (2016) 17:108 Page 7 of 7
